<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">VNqxFHK3sSg7J7Yp7X9jgYv</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2013000100005</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(13)10000100005</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012005000118</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Efeitos agudos do exerc&#237;cio f&#237;sico prolongado: avalia&#231;&#227;o ap&#243;s ultramaratona de 24 horas</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Passaglia</surname>
            <given-names>Daniela Guinther</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Emed</surname>
            <given-names>Luiz Gustavo Marin</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barberato</surname>
            <given-names>Silvio Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guerios</surname>
            <given-names>Surya Toledo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moser</surname>
            <given-names>Andre Isolani</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Miguel Morita Fernandes</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishie</surname>
            <given-names>Elissa</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guarita-Souza</surname>
            <given-names>Luiz Cesar</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costantini</surname>
            <given-names>Costantino Roberto Frack</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Faria-Neto</surname>
            <given-names>Jos&#233; Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Curitiba</named-content>
          <named-content content-type="state">Paran&#225;</named-content>
        </addr-line>
        <institution content-type="orgname">Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225;</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Curitiba</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Hospital Cardiol&#243;gico Costantini</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2013</year>
      </pub-date>
      <volume>100</volume>
      <issue>1</issue>
      <fpage>21</fpage>
      <lpage>28</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>02</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>30</day>
          <month>08</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: As consequ&#234;ncias e os riscos do exerc&#237;cio f&#237;sico cont&#237;nuo por per&#237;odos prolongados n&#227;o est&#227;o esclarecidos. OBJETIVO: Avaliar os efeitos do exerc&#237;cio prolongado em participantes de uma ultramaratona de 24 horas. M&#201;TODOS: Vinte corredores foram selecionados para avalia&#231;&#227;o, um dia antes e imediatamente ap&#243;s a prova em que os corredores devem percorrer a maior dist&#226;ncia em 24 horas. Foram obtidos dados cl&#237;nicos, laboratoriais e ecocardiogr&#225;ficos. RESULTADOS: A dist&#226;ncia m&#233;dia percorrida foi de 140,3 &#177; 18,7 km. Os corredores apresentaram redu&#231;&#227;o do peso corp&#243;reo (p &lt; 0,001) e da press&#227;o arterial sist&#243;lica (p &lt; 0,001) e diast&#243;lica (p = 0,004). As altera&#231;&#245;es hematol&#243;gicas foram compat&#237;veis com o estresse fisiol&#243;gico. A concentra&#231;&#227;o plasm&#225;tica de creatinofosfoquinase (CPK) aumentou significativamente (163,4 &#177; 56,8 versus 2978,4 &#177; 1921,9 U/L; p &lt; 0,001) e esteve inversamente correlacionada com a dist&#226;ncia percorrida: os que correram maiores dist&#226;ncias apresentaram n&#237;veis mais baixos de CPK (Pearson r = 0,69; p = 0,02). Ap&#243;s a corrida, dois corredores apresentaram discreta eleva&#231;&#227;o de troponina T. Em um deles, houve queda concomitante na fra&#231;&#227;o de eje&#231;&#227;o (coronariopatia foi exclu&#237;da subsequentemente). O ecocardiograma na avalia&#231;&#227;o basal mostrou hipertrofia de ventr&#237;culo esquerdo em um e aumento do volume atrial esquerdo em cinco corredores. Ap&#243;s a prova, houve redu&#231;&#227;o na rela&#231;&#227;o E/A (p &lt; 0,01). CONCLUS&#195;O: O exerc&#237;cio f&#237;sico prolongado est&#225; associado a altera&#231;&#245;es cardiovasculares e metab&#243;licas. As altera&#231;&#245;es cardiol&#243;gicas encontradas sugerem que o fen&#244;meno de fadiga card&#237;aca pode ocorrer nessa modalidade de corrida. O efeito a longo prazo dessas altera&#231;&#245;es, com a manuten&#231;&#227;o da pr&#225;tica desse tipo de atividade, ainda &#233; desconhecido.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Exerc&#237;cio</kwd>
        <kwd>esfor&#231;o f&#237;sico</kwd>
        <kwd>corrida</kwd>
        <kwd>fadiga muscular</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>18</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>Efeitos agudos do exerc&#237;cio f&#237;sico prolongado: avalia&#231;&#227;o ap&#243;s ultramaratona de 24 horas</p>
    <p>
      <bold>Daniela Guinther Passaglia<sup>I</sup>; Luiz Gustavo Marin Emed<sup>I,II</sup>; Silvio Henrique Barberato<sup>II</sup>; Surya Toledo Guerios<sup>I</sup>; Andre Isolani Moser<sup>I</sup>; Miguel Morita Fernandes Silva<sup>II</sup>; Elissa Ishie<sup>II</sup>; Luiz Cesar Guarita-Souza<sup>I</sup>; Costantino Roberto Frack Costantini<sup>II</sup>; Jos&#233; Rocha Faria-Neto<sup>I,II</sup></bold>
    </p>
    <p><sup>I</sup>Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225;; Curitiba, PR, Brasil </p>
    <p><sup>II</sup>Hospital Cardiol&#243;gico Costantini; Curitiba, PR, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> As consequ&#234;ncias e os riscos do exerc&#237;cio f&#237;sico cont&#237;nuo por per&#237;odos prolongados n&#227;o est&#227;o esclarecidos. </p>
    <p><bold> OBJETIVO:</bold> Avaliar os efeitos do exerc&#237;cio prolongado em participantes de uma ultramaratona de 24 horas. </p>
    <p><bold> M&#201;TODOS:</bold> Vinte corredores foram selecionados para avalia&#231;&#227;o, um dia antes e imediatamente ap&#243;s a prova em que os corredores devem percorrer a maior dist&#226;ncia em 24 horas. Foram obtidos dados cl&#237;nicos, laboratoriais e ecocardiogr&#225;ficos. </p>
    <p><bold> RESULTADOS:</bold> A dist&#226;ncia m&#233;dia percorrida foi de 140,3 &#177; 18,7 km. Os corredores apresentaram redu&#231;&#227;o do peso corp&#243;reo (p &lt; 0,001) e da press&#227;o arterial sist&#243;lica (p &lt; 0,001) e diast&#243;lica (p = 0,004). As altera&#231;&#245;es hematol&#243;gicas foram compat&#237;veis com o estresse fisiol&#243;gico. A concentra&#231;&#227;o plasm&#225;tica de creatinofosfoquinase (CPK) aumentou significativamente (163,4 &#177; 56,8 versus 2978,4 &#177; 1921,9 U/L; p &lt; 0,001) e esteve inversamente correlacionada com a dist&#226;ncia percorrida: os que correram maiores dist&#226;ncias apresentaram n&#237;veis mais baixos de CPK (Pearson r = 0,69; p = 0,02). Ap&#243;s a corrida, dois corredores apresentaram discreta eleva&#231;&#227;o de troponina T. Em um deles, houve queda concomitante na fra&#231;&#227;o de eje&#231;&#227;o (coronariopatia foi exclu&#237;da subsequentemente). O ecocardiograma na avalia&#231;&#227;o basal mostrou hipertrofia de ventr&#237;culo esquerdo em um e aumento do volume atrial esquerdo em cinco corredores. Ap&#243;s a prova, houve redu&#231;&#227;o na rela&#231;&#227;o E/A (p &lt; 0,01). </p>
    <p><bold> CONCLUS&#195;O:</bold> O exerc&#237;cio f&#237;sico prolongado est&#225; associado a altera&#231;&#245;es cardiovasculares e metab&#243;licas. As altera&#231;&#245;es cardiol&#243;gicas encontradas sugerem que o fen&#244;meno de fadiga card&#237;aca pode ocorrer nessa modalidade de corrida. O efeito a longo prazo dessas altera&#231;&#245;es, com a manuten&#231;&#227;o da pr&#225;tica desse tipo de atividade, ainda &#233; desconhecido.</p>
    <p><bold>Palavras-chave:</bold> Exerc&#237;cio, esfor&#231;o f&#237;sico, corrida, fadiga muscular.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A pr&#225;tica regular de exerc&#237;cio f&#237;sico est&#225; associada a efeitos ben&#233;ficos no controle dos fatores de risco e na redu&#231;&#227;o da mortalidade cardiovascular<sup>1</sup>. Parece haver uma rela&#231;&#227;o positiva entre dose e resposta ao treinamento f&#237;sico, mas ainda n&#227;o se sabe a intensidade a partir da qual haveria efeitos delet&#233;rios no sistema cardiovascular.</p>
    <p>A corrida &#233; uma modalidade esportiva em plena ascens&#227;o em todo o mundo. A cada ano, o n&#250;mero de eventos desse esporte se multiplica e o n&#250;mero de inscritos aumenta consideravelmente. Essa crescente popularidade, somada &#224; constante busca do ser humano pela supera&#231;&#227;o de seus limites, faz com que surjam provas extremamente desafiadoras. Consequentemente, aumenta o interesse sobre os efeitos agudos e eventuais riscos que tais atividades podem trazer aos atletas. A pr&#243;pria origem da maratona est&#225; associada ao relato de um caso de morte s&#250;bita.</p>
    <p>As evid&#234;ncias de que o exerc&#237;cio f&#237;sico extenuante pode causar altera&#231;&#245;es metab&#243;licas e no sistema cardiovascular s&#227;o provenientes de provas esportivas diversas<sup>2-6</sup>. Uma metan&#225;lise de 26 estudos demonstrou que ocorre eleva&#231;&#227;o da troponina em aproximadamente metade dos participantes de prova de <italic>endurance</italic>, e essa eleva&#231;&#227;o parece ser mais comum em provas de dura&#231;&#227;o mais curta<sup>7</sup>. Por outro lado, os efeitos agudos da atividade f&#237;sica cont&#237;nua e prolongada permanecem pouco explorados.</p>
    <p>A ultramaratona &#233; definida como uma corrida com dist&#226;ncia superior &#224; oficial da maratona (42.195 metros), podendo variar de acordo com determinada quilometragem ou limite de tempo. Estudos avaliando os efeitos cardiovasculares dos diferentes tipos de prova dessa modalidade s&#227;o escassos. O objetivo deste estudo foi avaliar os efeitos metab&#243;licos e hematol&#243;gicos e as altera&#231;&#245;es no sistema cardiovascular induzidas por uma ultramaratona de 24 horas, cujo objetivo &#233; percorrer a maior dist&#226;ncia nesse per&#237;odo.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Este estudo foi aprovado pelo comit&#234; de &#233;tica em pesquisa (CEP) da Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225; (PUC - PR), e o termo de consentimento livre e esclarecido (TCLE) de cada participante foi obtido por escrito antes de sua inclus&#227;o.</p>
    <p>O estudo foi realizado por ocasi&#227;o da "Ultramaratona 24 h - Corrotododia 2008", realizada na cidade de Curitiba, no dia 17/5/2008. A divulga&#231;&#227;o e as informa&#231;&#245;es iniciais sobre a pesquisa foram disponibilizadas no <italic>site </italic>da prova, junto &#224; ficha de inscri&#231;&#227;o. Os corredores que manifestaram interesse em participar do estudo foram contatados, via correio eletr&#244;nico, para envio de carta-convite e demais esclarecimentos. O evento totalizou 51 inscritos (nove mulheres e 42 homens).</p>
    <p>
      <bold>Crit&#233;rios de inclus&#227;o e exclus&#227;o</bold>
    </p>
    <p>Foram inclu&#237;dos apenas corredores do sexo masculino, com experi&#234;ncia em pelo menos uma corrida de longa dist&#226;ncia e sem relato de patologias cardiopulmonares. Os crit&#233;rios de exclus&#227;o foram: n&#227;o completar as 24 horas de prova ou n&#227;o realizar a coleta de sangue ou ecocardiograma em algum dos dois momentos (pr&#233; e p&#243;s-prova).</p>
    <p>
      <bold>Protocolo do estudo</bold>
    </p>
    <p>A prova foi realizada em uma pista externa de atletismo de 400 m, e a cada duas horas de prova os atletas alternavam o sentido da corrida. A altern&#226;ncia &#233; realizada por motivos psicol&#243;gicos, a fim de evitar principalmente a monotonia, e f&#237;sicos, evitando sobrecarga musculoesquel&#233;tica unilateral. Uma esta&#231;&#227;o de pesquisa foi montada no local do evento, com todo o material necess&#225;rio para a coleta dos dados. Todos os atletas responderam a um question&#225;rio de identifica&#231;&#227;o com informa&#231;&#245;es sobre situa&#231;&#227;o de sa&#250;de e hist&#243;rico esportivo.</p>
    <p>Durante a competi&#231;&#227;o foi permitido o livre consumo de l&#237;quidos (&#225;gua, refrigerantes e bebidas isot&#244;nicas) e alimenta&#231;&#227;o rica em carboidratos (frutas, macarr&#227;o, pur&#234; de batatas e sandu&#237;ches) dispon&#237;veis em tendas de apoio ao longo da pista. Da mesma maneira, era permitido descansar e caminhar durante o percurso pelo tempo que fosse necess&#225;rio. Entretanto, os atletas deveriam completar 24 horas da prova.</p>
    <p>
      <bold>Avalia&#231;&#227;o cl&#237;nica e laboratorial</bold>
    </p>
    <p>Os corredores foram submetidos a avalia&#231;&#227;o cl&#237;nica para obten&#231;&#227;o de dados antropom&#233;tricos antes e ap&#243;s a prova. Ap&#243;s as pesagens, em ambos os momentos, realizaram a bioimped&#226;ncia el&#233;trica em aparelho tetrapolar Maltron BF 906. Para a realiza&#231;&#227;o da mesma, o atleta foi colocado em dec&#250;bito dorsal em uma maca, com p&#233; e m&#227;o direitos ligeiramente afastados do tronco. Os eletrodos distais dos p&#233;s foram colocados na base do dedo m&#233;dio, e os proximais entre os mal&#233;olos medial e lateral. Nas m&#227;os, os eletrodos distais foram colocados na base do dedo m&#233;dio, com os eletrodos proximais coincidindo com o processo estiloide.</p>
    <p>Amostras de sangue venoso foram obtidas no dia anterior &#224; corrida e imediatamente ap&#243;s o t&#233;rmino. Em cada etapa, 20 ml de sangue foram coletados. As amostras foram imediatamente acondicionadas em gelo e protegidas da luz. No laborat&#243;rio, o plasma sangu&#237;neo foi separado por centrifuga&#231;&#227;o a 3.000 rota&#231;&#245;es por minuto durante 15 minutos e estocado em <italic>freezer </italic>a &#150;20 &#186;C at&#233; o momento das an&#225;lises. Cada amostra teve hemograma completo e an&#225;lises de ureia, creatinina, creatinofosfoquinase (CPK), creatina quinase MB (CK-MB), pot&#225;ssio e troponina card&#237;aca T (TnT).</p>
    <p>
      <bold>Ecocardiograma</bold>
    </p>
    <p>Estudo ecocardiogr&#225;fico completo (incluindo bidimensional, modo M e Doppler) foi realizado na noite anterior &#224; corrida e imediatamente ap&#243;s a prova, no pr&#243;prio local do evento. O aparelho utilizado foi o Agilant modelo Sonos 5500, Philips, equipado com transdutor de 2,5 mHz. Todas as imagens foram obtidas pelo mesmo ecocardiografista (SHB) e analisadas durante a execu&#231;&#227;o.</p>
    <p>As seguintes medidas lineares foram obtidas pelo modo M: espessura do septo interventricular em di&#225;stole, di&#226;metro diast&#243;lico e sist&#243;lico do ventr&#237;culo esquerdo (DDVE e DSVE) e espessura da parede posterior do ventr&#237;culo esquerdo (VE) em di&#225;stole.</p>
    <p>A massa do VE foi calculada de acordo com a equa&#231;&#227;o da Sociedade Americana de Ecocardiografia e indexada pela superf&#237;cie corp&#243;rea, diagnosticando hipertrofia de VE quando a massa indexada foi superior a 115 g/m<sup>2</sup>. A fun&#231;&#227;o sist&#243;lica do VE foi analisada pela fra&#231;&#227;o de eje&#231;&#227;o (FE), a qual foi calculada pelo m&#233;todo de Teichholz. As velocidades do fluxo transvalvar mitral no Doppler puls&#225;til foram registradas a partir do corte apical de quatro c&#226;maras com o volume da amostra posicionado nas extremidades dos folhetos da v&#225;lvula mitral durante respira&#231;&#227;o calma e controlada. Velocidade de enchimento r&#225;pido precoce (onda E), velocidade de contra&#231;&#227;o atrial (onda A) e rela&#231;&#227;o E/A foram estimadas de acordo com as recomenda&#231;&#245;es da Sociedade Americana de Ecocardiografia. As velocidades diast&#243;lica precoce (E') e tardia (A') do anel mitral ao Doppler tecidual, al&#233;m da rela&#231;&#227;o entre elas (E'/A'), foram registradas no corte apical de quatro c&#226;maras com amostra de volume de 1 mm na jun&#231;&#227;o da parede lateral do VE com o anel. O tamanho do &#225;trio esquerdo (AE) foi calculado pela estimativa do volume atrial esquerdo (VAE), o qual foi determinado pelo m&#233;todo biplanar de Simpson ao ecocardiograma bidimensional e indexado pela superf&#237;cie corp&#243;rea. Todas as medidas correspondem &#224; m&#233;dia de tr&#234;s ciclos card&#237;acos.</p>
    <p>A variabilidade intraobservador para as vari&#225;veis ecocardiogr&#225;ficas avaliadas neste estudo foi previamente publicada por nosso grupo<sup>8,9</sup>.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Os resultados est&#227;o expressos por m&#233;dias, medianas, valores m&#237;nimos e m&#225;ximos, e desvios padr&#245;es. Para avaliar o impacto da corrida sobre os dados obtidos nos dois momentos predeterminados (pr&#233; e p&#243;s-corrida), foi utilizado o teste <italic>t</italic> de Student para amostras emparelhadas. A condi&#231;&#227;o de normalidade das vari&#225;veis foi analisada pelo teste de Shapiro-Wilks. Valores de p &lt; 0,05 indicaram signific&#226;ncia estat&#237;stica.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Foram inclu&#237;dos 20 atletas no estudo. Doze completaram as 24 horas de prova e participaram de todas as etapas da pesquisa. Dos oito eliminados, tr&#234;s n&#227;o completaram a prova por problemas f&#237;sicos e cinco n&#227;o participaram de alguma etapa da avalia&#231;&#227;o.</p>
    <p>A idade m&#233;dia dos 12 participantes foi de 43,3 &#177; 9,9 anos. A dist&#226;ncia m&#233;dia percorrida foi de 140,32 km, compreendida entre 111,60 km e 169,60 km. A temperatura durante as 24 horas variou de 9-21 &#186;C.</p>
    <p>
      <bold>Dados cl&#237;nicos, antropom&#233;tricos e laboratoriais</bold>
    </p>
    <p>Em rela&#231;&#227;o &#224; avalia&#231;&#227;o pr&#233;-corrida, os corredores apresentaram redu&#231;&#227;o do peso, com perda m&#233;dia de 3,2% do peso inicial. Os dados da bioimped&#226;ncia demonstraram que n&#227;o houve altera&#231;&#227;o na composi&#231;&#227;o corporal de &#225;gua. Apesar desse achado, houve significativa redu&#231;&#227;o da press&#227;o arterial sist&#243;lica (120,8 &#177; 6,7 no pr&#233; <italic>versus</italic> 103,3 &#177; 8,9 no p&#243;s; p &lt; 0,001) e diast&#243;lica (83,3 &#177; 10,7 <italic>versus</italic> 73, 3 &#177; 8,9; p = 0,003). Os dados cl&#237;nicos e antropom&#233;tricos est&#227;o sumarizados na <xref ref-type="table" rid="tab01">Tabela 1</xref>.</p>
    <p content-type="asset">
      <table-wrap id="tab01">
        <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt01.jpg"/></table-wrap>
    </p>
    <p>Quanto aos achados laboratoriais, houve acentuada eleva&#231;&#227;o de CPK, marcador sens&#237;vel de inj&#250;ria muscular. Esse aumento foi acompanhado por eleva&#231;&#227;o da ureia, creatinina s&#233;rica e redu&#231;&#227;o da calemia. Na an&#225;lise hematol&#243;gica, observamos significativa leucocitose, predominantemente por neutrofilia. Os dados laboratoriais est&#227;o demonstrados na <xref ref-type="table" rid="tab02">Tabela 2</xref>. Conforme demonstrado na <xref ref-type="fig" rid="fig01">Figura 1</xref>, os n&#237;veis de CPK ap&#243;s a prova tiveram correla&#231;&#227;o inversa com a dist&#226;ncia percorrida na prova.</p>
    <p content-type="asset">
      <table-wrap id="tab02">
        <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt02.jpg"/></table-wrap>
    </p>
    <p content-type="asset">
      <fig id="fig01">
        <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gf01.jpg"/></fig>
    </p>
    <p>
      <bold>Marcadores de necrose mioc&#225;rdica</bold>
    </p>
    <p>Houve acentuada eleva&#231;&#227;o de CK-MB. Entretanto, tal modifica&#231;&#227;o ocorreu de maneira paralela &#224; eleva&#231;&#227;o de CPK (<xref ref-type="table" rid="tab02">Tabela 2</xref>). Em rela&#231;&#227;o &#224; troponina T, os valores encontrados na dosagem pr&#233;-prova estiveram abaixo do limiar de detec&#231;&#227;o do m&#233;todo (0,010 ng/ml). Ap&#243;s a prova, dois atletas apresentaram aumento nos valores (0,015 e 0,018 ng/ml), por&#233;m abaixo do valor de refer&#234;ncia para detec&#231;&#227;o de les&#227;o mioc&#225;rdica.</p>
    <p>
      <bold>Achados ecocardiogr&#225;ficos</bold>
    </p>
    <p>Na avalia&#231;&#227;o pr&#233;-prova, todos os atletas apresentavam fun&#231;&#227;o ventricular sist&#243;lica e diast&#243;lica normais. Hipertrofia do ventr&#237;culo esquerdo foi observada em um corredor e detectou-se aumento no volume do &#225;trio esquerdo em cinco corredores.</p>
    <p>O valor m&#233;dio do DDVE diminuiu significantemente (p &lt; 0,01), enquanto o do DSVE e o da FE permaneceram inalterados ap&#243;s a prova.</p>
    <p>Em rela&#231;&#227;o &#224; fun&#231;&#227;o diast&#243;lica do VE, observou-se diminui&#231;&#227;o na rela&#231;&#227;o E/A ap&#243;s a competi&#231;&#227;o (p = 0,001). Tal altera&#231;&#227;o ocorreu principalmente por aumento nos valores de A (p &lt; 0,001), sem modifica&#231;&#245;es no valor de E. Em paralelo, foram observadas queda na velocidade E' e aumento na velocidade A', que, embora n&#227;o significativos, levaram a uma varia&#231;&#227;o lim&#237;trofe da rela&#231;&#227;o E'/A' (p = 0,05).</p>
    <p>Finalmente, n&#227;o houve varia&#231;&#227;o no VAE. Os achados ecocardiogr&#225;ficos est&#227;o descritos na <xref ref-type="table" rid="tab03">Tabela 3</xref>.</p>
    <p content-type="asset">
      <table-wrap id="tab03">
        <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt03.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Fadiga card&#237;aca</bold>
    </p>
    <p>Um atleta, o mais idoso a completar a prova (63 anos), apresentou significativa redu&#231;&#227;o da FEVE: 70% pr&#233; e 51% p&#243;s-prova. A disfun&#231;&#227;o foi global, sem altera&#231;&#227;o da contra&#231;&#227;o segmentar. Clinicamente, observou-se taquidispneia acentuada no momento da chegada. Esse atleta foi posteriormente avaliado com cintilografia de perfus&#227;o mioc&#225;rdica e angiotomografia de coron&#225;rias, que descartaram coronariopatia ou outra cardiopatia estrutural. Salienta-se que esse foi um dos dois atletas a apresentar eleva&#231;&#227;o de troponina, ainda que abaixo do valor de refer&#234;ncia para diagn&#243;stico de les&#227;o mioc&#225;rdica.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Embora os efeitos ben&#233;ficos do exerc&#237;cio f&#237;sico na sa&#250;de global estejam demonstrados h&#225; longa data, permanecem obscuros os efeitos agudos do treinamento aer&#243;bico prolongado, em especial para o cora&#231;&#227;o. As competi&#231;&#245;es atl&#233;ticas de longa dura&#231;&#227;o, como ultramaratonas e outras provas envolvendo m&#250;ltiplas modalidades desportivas (como <italic>ironman</italic> e <italic>ultraman</italic>), tornam-se oportunidades &#250;nicas para esse tipo de avalia&#231;&#227;o. Por serem poucos os atletas aptos a realizar tais provas, os estudos dessa &#225;rea compreendem, em geral, pequeno n&#250;mero de indiv&#237;duos. Portanto, os resultados desse estudo somam-se a outros previamente publicados com o intuito de avaliar se o exerc&#237;cio f&#237;sico &#233; sempre ben&#233;fico ou se o seu excesso pode colocar em risco a sa&#250;de.</p>
    <p>Muitas das altera&#231;&#245;es observadas em nosso estudo confirmam os resultados de investiga&#231;&#245;es anteriores em provas de <italic>endurance</italic> prolongado. Sabe-se da ocorr&#234;ncia de eleva&#231;&#227;o de CPK ap&#243;s provas de grande estresse fisiol&#243;gico<sup>10-17</sup>, indicando intenso estado catab&#243;lico da musculatura esquel&#233;tica. A intensidade e a dura&#231;&#227;o do exerc&#237;cio f&#237;sico est&#227;o associadas comumente &#224; eleva&#231;&#227;o de CPK, parecendo haver um efeito predominante da dura&#231;&#227;o<sup>16</sup>. Embora rara, pode ocorrer rabdomi&#243;lise severa, por&#233;m de forma mais comum em indiv&#237;duos menos treinados submetidos a exerc&#237;cio f&#237;sico extenuante em temperatura elevada<sup>18</sup>. &#201; interessante notar em nosso estudo a estreita rela&#231;&#227;o inversa observada entre os n&#237;veis de CPK e a dist&#226;ncia percorrida. Os atletas que percorreram as maiores dist&#226;ncias apresentaram n&#237;veis mais baixos de CPK, mostrando que o volume do esfor&#231;o n&#227;o &#233; necessariamente o grande determinante da eleva&#231;&#227;o. Pode-se supor que o melhor condicionamento f&#237;sico, que levou os atletas a percorrerem maior dist&#226;ncia, tamb&#233;m evitou maior catabolismo muscular. Estudos anteriores mostram que o treinamento f&#237;sico realmente atenua a libera&#231;&#227;o de CPK em um mesmo indiv&#237;duo<sup>19</sup>.</p>
    <p>A eleva&#231;&#227;o de ureia e creatinina &#233; outro achado comum em provas de treinamento f&#237;sico extenuante, mas seu significado &#233; menos claro. Embora possa refletir grande degrada&#231;&#227;o de creatina muscular, n&#227;o encontramos correla&#231;&#227;o entre a varia&#231;&#227;o de creatinina e a eleva&#231;&#227;o de CPK (dado n&#227;o mostrado). Outros mecanismos podem estar associados a essas eleva&#231;&#245;es, como a redu&#231;&#227;o do fluxo sangu&#237;neo renal e a taxa de filtra&#231;&#227;o glomerular. Les&#227;o renal discreta, por&#233;m persistente, j&#225; foi demonstrada em alguns atletas de alto desempenho<sup>20</sup>. A pr&#243;pria hipovolemia pode ser uma das causas de eleva&#231;&#227;o da creatinina<sup>15</sup>. O aumento da ureia pode ser explicado pelo aumento do estado catab&#243;lico.</p>
    <p>Dentre as altera&#231;&#245;es metab&#243;licas, observamos discreta redu&#231;&#227;o da calemia nos corredores. Esse achado op&#245;e-se ao descrito na literatura sobre as altera&#231;&#245;es nas concentra&#231;&#245;es desse eletr&#243;lito em decorr&#234;ncia da pr&#225;tica de exerc&#237;cios<sup>11</sup>. A possibilidade de alimenta&#231;&#227;o e hidrata&#231;&#227;o adequada na prova possivelmente colaborou para a aus&#234;ncia de altera&#231;&#245;es eletrol&#237;ticas mais significativas.</p>
    <p>A aus&#234;ncia de altera&#231;&#245;es na bioimped&#226;ncia deve ser interpretada com ressalvas, visto que a realiza&#231;&#227;o imediatamente ap&#243;s exerc&#237;cio intenso pode reduzir sua acur&#225;cia para a medida da &#225;gua corporal total. As altera&#231;&#245;es hemodin&#226;micas, como o aumento do d&#233;bito card&#237;aco e da perfus&#227;o muscular esquel&#233;tica, e o processo de dissipa&#231;&#227;o de calor, com vasodilata&#231;&#227;o cut&#226;nea, aumento da temperatura da pele e sudorese, reduzem a imped&#226;ncia corporal, afetando os resultados. Isso pode ter limitado a an&#225;lise por bioimped&#226;ncia em detectar a desidrata&#231;&#227;o inferida pela medida do peso corporal. A ingest&#227;o de l&#237;quidos foi livre e a crit&#233;rio do atleta neste estudo, permitindo avaliar os efeitos do exerc&#237;cio prolongado nas condi&#231;&#245;es em que esse tipo de prova &#233; habitualmente realizada. Observamos que a m&#233;dia de redu&#231;&#227;o do peso foi de 3,2%, que se encontra dentro da faixa de desidrata&#231;&#227;o significativa segundo a National Athletic Trainer's Association<sup>21</sup>. No entanto, a estimativa do grau de desidrata&#231;&#227;o a partir das mudan&#231;as no peso vem sendo questionada. Recentemente, Knechtle e cols.<sup>22</sup> encontraram redu&#231;&#227;o m&#233;dia de 2,5% do peso de atletas ap&#243;s uma ultramaratona de 100 km, que n&#227;o pode ser explicada totalmente pela redu&#231;&#227;o da &#225;gua corporal total, sugerindo que seja decorrente de perda de massa s&#243;lida (massa muscular e gordura).</p>
    <p>N&#227;o foi observada mudan&#231;a no hemat&#243;crito ou n&#237;veis de hemoglobina semelhante ao que foi encontrado em estudos pr&#233;vios com ultramaratonistas<sup>23</sup>. O aumento da atividade da vasopressina e da aldosterona plasm&#225;tica promovendo a manuten&#231;&#227;o ou o aumento do volume plasm&#225;tico &#233; uma poss&#237;vel explica&#231;&#227;o para esse achado. J&#225; as altera&#231;&#245;es leucocit&#225;rias estiveram de acordo com o que se espera em situa&#231;&#245;es de estresse. Ocorreu significativa leucocitose, com acentuada forma&#231;&#227;o de neutr&#243;filos. As altera&#231;&#245;es linfocit&#225;rias t&#234;m resultados mais divergentes, embora alguns estudos corroborem nossos achados de linfocitose<sup>11</sup>.</p>
    <p>Em rela&#231;&#227;o &#224; avalia&#231;&#227;o de dano mioc&#225;rdico em atletas, &#233; fundamental a correta interpreta&#231;&#227;o dos testes laboratoriais. Uma vez que a les&#227;o de musculatura esquel&#233;tica tamb&#233;m altera marcadores habitualmente usados para avalia&#231;&#227;o mioc&#225;rdica, marcadores sens&#237;veis e espec&#237;ficos, como as troponinas card&#237;acas T e I, devem ser utilizados. A avalia&#231;&#227;o de CPK e CKMB falha em diferenciar les&#227;o do mioc&#225;rdio da que ocorre na musculatura esquel&#233;tica. Diversos estudos, como o nosso, n&#227;o demonstraram eleva&#231;&#227;o de TnT, mesmo com significativas eleva&#231;&#245;es de CKMB<sup>24-28</sup>. Outros mostraram eleva&#231;&#227;o desse marcador em um grupo heterog&#234;neo de atletas<sup>29-33</sup>, embora ainda n&#227;o se saiba se essa eleva&#231;&#227;o reflete realmente dano mioc&#225;rdico e quais seriam os determinantes de altera&#231;&#227;o apenas em alguns atletas. Um estudo experimental de Chen e cols.<sup>34</sup> demonstrou em ratos que o grau de les&#227;o mioc&#225;rdica induzida por esfor&#231;o f&#237;sico extenuante &#233; dependente do pr&#233;vio condicionamento f&#237;sico. Se &#233; uma explica&#231;&#227;o para os achados discrepantes em seres humanos, ainda &#233; uma hip&#243;tese a ser testada. Entretanto, um pequeno estudo realizado com maratonistas mostrou realmente maior libera&#231;&#227;o de troponina em corredores menos treinados<sup>35</sup>. Em uma metan&#225;lise, Shave e cols.<sup>36</sup> demonstraram que a libera&#231;&#227;o de cTnT induzida pelo exerc&#237;cio &#233; evidente em quase metade dos atletas de <italic>endurance</italic>, sendo mais propensos os atletas relativamente mais pesados competindo em provas de longa dist&#226;ncia.</p>
    <p>Embora nenhum atleta neste estudo tenha apresentado eleva&#231;&#227;o de troponina acima do valor de refer&#234;ncia para diagn&#243;stico de dano mioc&#225;rdico, dois corredores passaram a apresentar n&#237;veis detect&#225;veis ap&#243;s a prova. Em estudo pr&#233;vio com participantes de uma prova de <italic>ironman</italic>, mesmo altera&#231;&#245;es discretas de troponina estiveram associadas a altera&#231;&#245;es ecocardiogr&#225;ficas<sup>37</sup>. Essas altera&#231;&#245;es configuram o quadro da fadiga card&#237;aca, uma entidade descrita h&#225; v&#225;rios anos, mas de etiologia ainda indefinida. Acredita-se que o estresse gerado pelo exerc&#237;cio f&#237;sico nas paredes de ventr&#237;culo esquerdo e direito seja a origem dessas altera&#231;&#245;es<sup>38</sup>. O aumento na concentra&#231;&#227;o plasm&#225;tica de pept&#237;deo natriur&#233;tico cerebral (BNP) em atletas de <italic>endurance</italic> refor&#231;a essa ideia<sup>39</sup>.</p>
    <p>Em nossa amostra, o &#250;nico atleta que apresentou queda significativa da FEVE ao t&#233;rmino da corrida foi justamente um dos que apresentaram eleva&#231;&#227;o, ainda que discreta, de troponina. Afastada a possibilidade de les&#227;o isqu&#234;mica por exame funcional (cintilografia mioc&#225;rdica) e anat&#244;mico (angiotomografia de coron&#225;rias), o diagn&#243;stico estabelecido foi de fadiga card&#237;aca. Entretanto, o achado de redu&#231;&#227;o da FEVE nesse paciente foi isolado. A an&#225;lise ecocardiogr&#225;fica n&#227;o mostrou diminui&#231;&#227;o na fun&#231;&#227;o sist&#243;lica do VE, demonstrando que nos demais corredores a intensidade do exerc&#237;cio n&#227;o foi suficiente para induzir significativa deteriora&#231;&#227;o na contratilidade card&#237;aca.</p>
    <p>Em rela&#231;&#227;o &#224; fun&#231;&#227;o diast&#243;lica, o achado ecocardiogr&#225;fico de significativa redu&#231;&#227;o da rela&#231;&#227;o E/A, comumente interpretado como aparecimento de disfun&#231;&#227;o diast&#243;lica, foi anteriormente descrito<sup>40</sup>. Aqui se faz necess&#225;rio um ju&#237;zo cr&#237;tico da express&#227;o "disfun&#231;&#227;o diast&#243;lica" ap&#243;s exerc&#237;cio f&#237;sico prolongado. Embora tal conclus&#227;o seja proveniente de dados derivados do Doppler convencional do fluxo mitral(reconhecidamente dependentes da pr&#233;-carga), nosso estudo mostrou varia&#231;&#227;o apenas marginal na rela&#231;&#227;o E'/A', esta obtida pelo Doppler tecidual e menos suscet&#237;vel &#224;s condi&#231;&#245;es de carga<sup>9</sup>. Assim, se por um lado pode ter ocorrido uma casu&#237;stica insuficiente para demonstrar diferen&#231;as expressivas nas velocidades E' e A' que corroborassem a hip&#243;tese de real disfun&#231;&#227;o diast&#243;lica, por outro lado a diminui&#231;&#227;o da rela&#231;&#227;o E/A ap&#243;s o esfor&#231;o pode correlacionar-se meramente &#224; redu&#231;&#227;o da pr&#233;-carga. Em paralelo, devemos destacar que tal altera&#231;&#227;o foi secund&#225;ria ao aumento da onda A (fase da contra&#231;&#227;o atrial), sem altera&#231;&#227;o nos valores de E (fase de enchimento r&#225;pido). Da mesma forma que &#233; razo&#225;vel supor que a diminui&#231;&#227;o do di&#226;metro do VE decorre da queda na pr&#233;-carga, pode-se especular que o aumento da onda A possa ser secund&#225;rio &#224; redu&#231;&#227;o concomitante da p&#243;s-carga, com acr&#233;scimos na contratilidade atrial e complac&#234;ncia ventricular. Portanto, a diminui&#231;&#227;o da rela&#231;&#227;o E/A n&#227;o representaria real disfun&#231;&#227;o diast&#243;lica (exceto no caso supracitado de fadiga card&#237;aca), mas o efeito complexo das altera&#231;&#245;es hemodin&#226;micas sobre o volume sangu&#237;neo total e a fisiologia cardiovascular. Estudos posteriores dever&#227;o esclarecer se o esfor&#231;o f&#237;sico extenuante promove real preju&#237;zo do relaxamento mioc&#225;rdico.</p>
    <p>Nosso estudo apresenta algumas limita&#231;&#245;es. O n&#250;mero de sujeitos inclu&#237;dos n&#227;o foi baseado em c&#225;lculo amostral, mas no n&#250;mero total de indiv&#237;duos que aceitaram participar desta pesquisa. Por tratar-se de prova extenuante, o n&#250;mero de inscritos foi reduzido. Mesmo assim, cerca de 50% dos corredores do sexo masculino consentiram na participa&#231;&#227;o, percentual maior do que na maioria das publica&#231;&#245;es com popula&#231;&#245;es semelhantes. Outra limita&#231;&#227;o foi a falta de avalia&#231;&#227;o da capacidade aer&#243;bica dos corredores. A avalia&#231;&#227;o pr&#233;via do consumo m&#225;ximo de oxig&#234;nio (VO<sub>2 </sub>m&#225;x) permitiria melhor compreens&#227;o se determinados achados n&#227;o refletissem, na verdade, menor capacidade cardiorrespirat&#243;ria. Por fim, avalia&#231;&#227;o &#250;nica no p&#243;s-prova imediato n&#227;o nos permite qualquer infer&#234;ncia sobre a evolu&#231;&#227;o temporal das altera&#231;&#245;es metab&#243;licas e cardiovasculares encontradas. Como a maioria dos corredores era de outras cidades, uma avalia&#231;&#227;o posterior tornou-se invi&#225;vel.</p>
    <p>Em conclus&#227;o, a corrida de ultramaratona esteve associada a diversas altera&#231;&#245;es metab&#243;licas, hematol&#243;gicas e cardiovasculares. Em rela&#231;&#227;o &#224; musculatura esquel&#233;tica, p&#244;de-se observar menor grau de les&#227;o nos corredores que percorreram maiores dist&#226;ncias. Eleva&#231;&#227;o discreta de TnT esteve associada a disfun&#231;&#227;o sist&#243;lica de VE em um corredor, em quadro compat&#237;vel com fadiga card&#237;aca. Nos demais, o achado de queda da rela&#231;&#227;o E/A ao Doppler mitral foi predominante. O efeito a longo prazo desse tipo de exerc&#237;cio f&#237;sico prolongado ainda &#233; desconhecido.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de mestrado de Daniela G. Passaglia pela Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225;.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p>Jos&#233; Rocha Faria-Neto </p>
        <p> Rua Prof. Pedro V. Parigot de Souza, 2019 / 1101 </p>
        <p> Mossungu&#234; &#150; CEP 81200-100 </p>
        <p> Curitiba, PR, Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="jrochafaria@cardiol.br">jrochafaria@cardiol.br</email>, </p>
        <p>
          <email xlink:href="jose.faria@pucpr.br">jose.faria@pucpr.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 21/02/12 </p>
    <p> revisado recebido em 30/08/12 </p>
    <p> aceito em 18/10/12.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328(8):538-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The association of changes in physical-activity level and other lifestyle characteristics with mortality among men</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>538</fpage>
          <lpage>45</lpage>
          <issue>8</issue>
          <volume>328</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Paffenbarger Jr</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Wing</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Kampert</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the boston marathon. Circulation. 2006;114(22):2325-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the boston marathon</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2325</fpage>
          <lpage>33</lpage>
          <issue>22</issue>
          <volume>114</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Neilan</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Januzzi</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lee-Lewandrowski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ton-Nu</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Yoerger</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Jassal</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin t and commercial cardiac troponin t and i assays. Clin Chem. 2009;55(1):101-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reference population and marathon runner sera assessed by highly sensitive cardiac troponin t and commercial cardiac troponin t and i assays</article-title>
          <source>Clin Chem</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>101</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mingels</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Michielsen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Swaanenburg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wodzig</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>van Dieijen-Visser</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Mousavi N, Czarnecki A, Kumar K, Fallah-Rad N, Lytwyn M, Han SY, et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009;103(10):1467-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relation of biomarkers and cardiac magnetic resonance imaging after marathon running</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1467</fpage>
          <lpage>72</lpage>
          <issue>10</issue>
          <volume>103</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mousavi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Czarnecki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fallah-Rad</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lytwyn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, et al. Cardiac troponin increases among runners in the boston marathon. Ann Emerg Med. 2007;49(2):137-43, 43 e1.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac troponin increases among runners in the boston marathon</article-title>
          <source>Ann Emerg Med</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>137</fpage>
          <lpage>43</lpage>
          <issue>2</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fortescue</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Greenes</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Mannix</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Tulloh L, Robinson D, Patel A, Ware A, Prendergast C, Sullivan D, et al. Raised troponin t and echocardiographic abnormalities after prolonged strenuous exercise--the australian ironman triathlon. Br J Sports Med. 2006;40(7):605-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Raised troponin t and echocardiographic abnormalities after prolonged strenuous exercise--the australian ironman triathlon</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>605</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tulloh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prendergast</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, et al. Exercise-induced cardiac troponin t release: a meta-analysis. Med Sci Sports Exerc. 2007;39(12):2099-106.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise-induced cardiac troponin t release: a meta-analysis</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2099</fpage>
          <lpage>106</lpage>
          <issue>12</issue>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Shave</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Middleton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Whyte</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Barberato SH, Mantilla DE, Misocami MA, Goncalves SM, Bignelli AT, Riella MC, et al. Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic doppler parameters in patients with end-stage renal disease. Am J Cardiol. 2004;94(9):1208-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic doppler parameters in patients with end-stage renal disease</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1208</fpage>
          <lpage>10</lpage>
          <issue>9</issue>
          <volume>94</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barberato</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Mantilla</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Misocami</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bignelli</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Riella</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Barberato SH, Pecoits Filho R. Influ&#234;ncia da redu&#231;&#227;o da pr&#233;-carga sobre o &#237;ndice de desempenho mioc&#225;rdico (&#237;ndice de Tei) e outros par&#226;metros doppler ecocardiogr&#225;ficos da fun&#231;&#227;o ventricular esquerda. Arq Bras Cardiol. 2006;86(6):425-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influ&#234;ncia da redu&#231;&#227;o da pr&#233;-carga sobre o &#237;ndice de desempenho mioc&#225;rdico (&#237;ndice de Tei) e outros par&#226;metros doppler ecocardiogr&#225;ficos da fun&#231;&#227;o ventricular esquerda</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>425</fpage>
          <lpage>31</lpage>
          <issue>6</issue>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barberato</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Pecoits Filho</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Musha H, Nagashima J, Awaya T, Oomiya K, Takada H, Murayama M. Myocardial injury in a 100-km ultramarathon. Current Therapeutic Research. 1997;58(9):587-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial injury in a 100-km ultramarathon</article-title>
          <source>Current Therapeutic Research</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>587</fpage>
          <lpage>93</lpage>
          <issue>9</issue>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Musha</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagashima</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Awaya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oomiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murayama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Rama R, Ibanez J, Riera M, Prats MT, Pages T, Palacios L. Hematological, electrolyte, and biochemical alterations after a 100-km run. Can J Appl Physiol. 1994;19(4):411-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hematological, electrolyte, and biochemical alterations after a 100-km run</article-title>
          <source>Can J Appl Physiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>411</fpage>
          <lpage>20</lpage>
          <issue>4</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rama</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ibanez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Riera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Prats</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Pages</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Palacios</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. van Rensburg JP, Kielblock AJ, van der Linde A. Physiologic and biochemical changes during a triathlon competition. Int J Sports Med. 1986;7(1):30-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physiologic and biochemical changes during a triathlon competition</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>30</fpage>
          <lpage>5</lpage>
          <issue>1</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>van Rensburg</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Kielblock</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Bessa A, Nissenbaum M, Monteiro A, Gandra PG, Nunes LS, Bassini-Cameron A, et al. High-intensity ultraendurance promotes early release of muscle injury markers. Br J Sports Med. 2008;42(11):589-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>High-intensity ultraendurance promotes early release of muscle injury markers</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>589</fpage>
          <lpage>93</lpage>
          <issue>11</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bessa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nissenbaum</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monteiro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gandra</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Bassini-Cameron</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. La Gerche A, Boyle A, Wilson AM, Prior DL. No evidence of sustained myocardial injury following an ironman distance triathlon. Int J Sports Med. 2004;25(1):45-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>No evidence of sustained myocardial injury following an ironman distance triathlon</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>45</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>La Gerche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Prior</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Fallon KE, Sivyer G, Sivyer K, Dare A. The biochemistry of runners in a 1600 km ultramarathon. Br J Sports Med. 1999;33(4):264-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The biochemistry of runners in a 1600 km ultramarathon</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>264</fpage>
          <lpage>9</lpage>
          <issue>4</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fallon</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Sivyer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sivyer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dare</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Noakes TD. Effect of exercise on serum enzyme activities in humans. Sports Med. 1987;4(4):245-67.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of exercise on serum enzyme activities in humans</article-title>
          <source>Sports Med</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>245</fpage>
          <lpage>67</lpage>
          <issue>4</issue>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Noakes</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Nagel D, Seiler D, Franz H, Jung K. Ultra-long-distance running and the liver. Int J Sports Med. 1990;11(6):441-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ultra-long-distance running and the liver</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>441</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nagel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Franz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Knochel JP. Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis". Kidney Int. 1990;38(4):709-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis"</article-title>
          <source>Kidney Int</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>709</fpage>
          <lpage>19</lpage>
          <issue>4</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Knochel</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Warburton DE, Welsh RC, Haykowsky MJ, Taylor DA, Humen DP. Biochemical changes as a result of prolonged strenuous exercise. Br J Sports Med. 2002;36(4):301-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Biochemical changes as a result of prolonged strenuous exercise</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>301</fpage>
          <lpage>3</lpage>
          <issue>4</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Warburton</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Welsh</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Haykowsky</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Humen</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Melamed I, Romem Y, Keren G, Epstein Y, Dolev E. March myoglobinemia: a hazard to renal function. Arch Intern Med. 1982;142(7):1277-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>March myoglobinemia: a hazard to renal function</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>1277</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>142</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Melamed</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Romem</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Keren</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dolev</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Casa DJ, Armstrong LE, Hillman SK, Montain SJ, Reiff RV, Rich BS, et al. National athletic trainers' association position statement: fluid replacement for athletes. J Athl Train. 2000;35(2):212-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>National athletic trainers' association position statement: fluid replacement for athletes</article-title>
          <source>J Athl Train</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>212</fpage>
          <lpage>24</lpage>
          <issue>2</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Casa</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Hillman</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Montain</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Reiff</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Rich</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Knechtle B, Knechtle P, Wirth A, Alexander Rust C, Rosemann T. A faster running speed is associated with a greater body weight loss in 100-km ultra-marathoners. J Sports Sci. 2012;30(11):1131-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A faster running speed is associated with a greater body weight loss in 100-km ultra-marathoners</article-title>
          <source>J Sports Sci</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>1131</fpage>
          <lpage>40</lpage>
          <issue>11</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Knechtle</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Knechtle</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alexander Rust</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rosemann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Burge J, Knechtle B, Knechtle P, Gnadinger M, Rust AC, Rosemann T. Maintained serum sodium in male ultra-marathoners--the role of fluid intake, vasopressin, and aldosterone in fluid and electrolyte regulation. Horm Metab Res. 2011;43(9):646-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Maintained serum sodium in male ultra-marathoners--the role of fluid intake, vasopressin, and aldosterone in fluid and electrolyte regulation</article-title>
          <source>Horm Metab Res</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>646</fpage>
          <lpage>52</lpage>
          <issue>9</issue>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Burge</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Knechtle</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Knechtle</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gnadinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rust</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Rosemann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Mair J, Wohlfarter T, Koller A, Mayr M, Artner-Dworzak E, Puschendorf B. Serum cardiac troponin t after extraordinary endurance exercise. Lancet. 1992;340(8826):1048.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serum cardiac troponin t after extraordinary endurance exercise</article-title>
          <source>Lancet</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>1048</fpage>
          <issue>8826</issue>
          <volume>340</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mair</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wohlfarter</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mayr</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Artner-Dworzak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Puschendorf</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Artner-Dworzak E, Mair J, Seibt I, Koller A, Haid C, Puschendorf B. Cardiac troponin t identifies unspecific increases of ckmb after physical exercise. Clin Chem. 1990;36(10):1853.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac troponin t identifies unspecific increases of ckmb after physical exercise</article-title>
          <source>Clin Chem</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>1853</fpage>
          <issue>10</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Artner-Dworzak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mair</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seibt</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haid</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Puschendorf</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Roth HJ, Leithauser RM, Doppelmayr H, Doppelmayr M, Finkernagel H, von Duvillard SP, et al. Cardiospecificity of the 3rd generation cardiac troponin t assay during and after a 216 km ultra-endurance marathon run in death valley. Clin Res Cardiol. 2007;96(6):359-64.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiospecificity of the 3rd generation cardiac troponin t assay during and after a 216 km ultra-endurance marathon run in death valley</article-title>
          <source>Clin Res Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>359</fpage>
          <lpage>64</lpage>
          <issue>6</issue>
          <volume>96</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Leithauser</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Doppelmayr</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Doppelmayr</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Finkernagel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>von Duvillard</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Lucia A, Serratosa L, Saborido A, Pardo J, Boraita A, Moran M, et al. Short-term effects of marathon running: No evidence of cardiac dysfunction. Med Sci Sports Exerc. 1999;31(10):1414-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Short-term effects of marathon running: No evidence of cardiac dysfunction</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1414</fpage>
          <lpage>21</lpage>
          <issue>10</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lucia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Serratosa</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Saborido</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pardo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Boraita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Bonetti A, Tirelli F, Albertini R, Monica C, Monica M, Tredici G. Serum cardiac troponin t after repeated endurance exercise events. Int J Sports Med. 1996;17(4):259-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serum cardiac troponin t after repeated endurance exercise events</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>259</fpage>
          <lpage>62</lpage>
          <issue>4</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bonetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tirelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Albertini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Monica</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Monica</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tredici</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Musha H, Nagashima J, Awaya T, Oomiya K, Takada H, Murayama M. Myocardial injury in a 100-km ultramarathon. Curr Ther Res. 1997;58(9):587-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial injury in a 100-km ultramarathon</article-title>
          <source>Curr Ther Res</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>587</fpage>
          <lpage>93</lpage>
          <issue>9</issue>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Musha</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagashima</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Awaya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oomiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murayama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Rifai N, Douglas PS, O'Toole M, Rimm E, Ginsburg GS. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol. 1999;83(7):1085-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1085</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rifai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>O'Toole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rimm</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise. JAMA. 1999;282(19):1816.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Regular exercise and subclinical myocardial injury during prolonged aerobic exercise</article-title>
          <source>JAMA</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1816</fpage>
          <issue>19</issue>
          <volume>282</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Koller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Summer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Whyte GP, George K, Sharma S, Lumley S, Gates P, Prasad K, et al. Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc. 2000;32(6):1067-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac fatigue following prolonged endurance exercise of differing distances</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1067</fpage>
          <lpage>72</lpage>
          <issue>6</issue>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Whyte</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lumley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gates</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Siegel AJ, Sholar M, Yang J, Dhanak E, Lewandrowski KB. Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned? Cardiology. 1997;88(6):487-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned?</article-title>
          <source>Cardiology</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>487</fpage>
          <lpage>91</lpage>
          <issue>6</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Siegel</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Sholar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dhanak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lewandrowski</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Chen Y, Serfass RC, Mackey-Bojack SM, Kelly KL, Titus JL, Apple FS. Cardiac troponin t alterations in myocardium and serum of rats after stressful, prolonged intense exercise. J Appl Physiol. 2000;88(5):1749-55.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac troponin t alterations in myocardium and serum of rats after stressful, prolonged intense exercise</article-title>
          <source>J Appl Physiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1749</fpage>
          <lpage>55</lpage>
          <issue>5</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Serfass</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Mackey-Bojack</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Titus</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Apple</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise. JAMA. 1999;282(19):1816.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Regular exercise and subclinical myocardial injury during prolonged aerobic exercise</article-title>
          <source>JAMA</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1816</fpage>
          <issue>19</issue>
          <volume>282</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Koller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Summer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc. 2007;39(12):2099-106.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise-induced cardiac troponin T release: a meta-analysis</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2099</fpage>
          <lpage>106</lpage>
          <issue>12</issue>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Shave</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Middleton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Whyte</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Tulloh L, Robinson D, Patel A, Ware A, Prendergast C, Sullivan D, et al. Raised troponin t and echocardiographic abnormalities after prolonged strenuous exercisethe australian ironman triathlon. Br J Sports Med. 2006;40(7):605-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Raised troponin t and echocardiographic abnormalities after prolonged strenuous exercise-the australian ironman triathlon</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>605</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tulloh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prendergast</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Kasikcioglu E. From altus to parvus: cardiac fatigue in athletes. Eur Heart J. 2007;28(9):1171-2.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>From altus to parvus: cardiac fatigue in athletes</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1171</fpage>
          <lpage>2</lpage>
          <issue>9</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kasikcioglu</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Banfi G, Lippi G, Susta D, Barassi A, Melzi d'Eril G, Dogliotti G, et al. Nt-proBNP concentrations in mountain marathoners. J Strength Cond Res. 2010;24(5):1369-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nt-proBNP concentrations in mountain marathoners</article-title>
          <source>J Strength Cond Res</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>1369</fpage>
          <lpage>72</lpage>
          <issue>5</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Banfi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lippi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Susta</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barassi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melzi d'Eril</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dogliotti</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Niemela K, Palatsi I, Ikaheimo M, Airaksinen J, Takkunen J. Impaired left ventricular diastolic function in athletes after utterly strenuous prolonged exercise. Int J Sports Med. 1987;8(2):61-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impaired left ventricular diastolic function in athletes after utterly strenuous prolonged exercise</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>61</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Niemela</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Palatsi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ikaheimo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Airaksinen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Takkunen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Acute effects of prolonged physical exercise: evaluation after a twenty-four-hour ultramarathon</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The consequences and risks of prolonged physical exercise are not well established. OBJECTIVE: To evaluate the effects of prolonged physical exercise on the participants of a 24-hour ultramarathon race. METHODS: Twenty male runners were selected for evaluation a day before and immediately after the race, where the athletes had to cover the most distance in 24 hours. Clinical, laboratory and echocardiographic data were obtained at both evaluations. RESULTS: Mean distance covered was 140.3 &#177; 18.7 km. Runners showed weight loss (p &lt; 0.001) and decrease in systolic (p &lt; 0.001) and diastolic (p = 0.004) blood pressure. Hematological changes were compatible with the physiological stress. Plasma levels of creatine phosphokinase strikingly increased post-race (163.4 &#177; 56.8 vs. 2978.4 &#177; 1921.9 U/L; p &lt; 0.001) and was inversely correlated with distance covered: those who covered the longest distances showed the lowest CPK levels (Pearson r = 0.69, p = 0.02). After the race, 2 runners showed a slight increase in Troponin levels. One of them also had simultaneous decrease in left ventricular ejection fraction (coronary artery disease was subsequently ruled out). Basal echocardiography assessment had shown LV hypertrophy in one and increased left atrial volume in five runners. After the race, there was a decrease in E/A ratio (p &lt; 0.01). CONCLUSION: Prolonged physical exercise is associated with metabolic and cardiovascular alterations. Cardiac abnormalities found in our study suggest that cardiac fatigue may occur in this specific race modality. The long-term effect of these alterations, while maintaining the routine practice of prolonged strenuous physical activity, is still unknown.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Exercise</kwd>
        <kwd>physical exertion</kwd>
        <kwd>running</kwd>
        <kwd>muscle fatigue</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p><undefined id="tx-body2"/>Acute effects of prolonged physical exercise: evaluation after a twenty-four-hour ultramarathon</p>
      <p>
        <bold>Daniela Guinther Passaglia<sup>I</sup>; Luiz Gustavo Marin Emed<sup>I,II</sup>; Silvio Henrique Barberato<sup>II</sup>; Surya Toledo Guerios<sup>I</sup>; Andre Isolani Moser<sup>I</sup>; Miguel Morita Fernandes Silva<sup>II</sup>; Elissa Ishie<sup>II</sup>; Luiz Cesar Guarita-Souza<sup>I</sup>; Costantino Roberto Frack Costantini<sup>II</sup>; Jos&#233; Rocha Faria-Neto<sup>I,II</sup></bold>
      </p>
      <p><sup>I</sup>Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225;; Curitiba, PR, Brazil</p>
      <p><sup>II</sup>Hospital Cardiol&#243;gico Costantini; Curitiba, PR, Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> The consequences and risks of prolonged physical exercise are not well established.</p>
      <p><bold> OBJECTIVE:</bold> To evaluate the effects of prolonged physical exercise on the participants of a 24-hour ultramarathon race.</p>
      <p><bold> METHODS:</bold> Twenty male runners were selected for evaluation a day before and immediately after the race, where the athletes had to cover the most distance in 24 hours. Clinical, laboratory and echocardiographic data were obtained at both evaluations.</p>
      <p><bold> RESULTS:</bold> Mean distance covered was 140.3 &#177; 18.7 km. Runners showed weight loss (p &lt; 0.001) and decrease in systolic (p &lt; 0.001) and diastolic (p = 0.004) blood pressure. Hematological changes were compatible with the physiological stress. Plasma levels of creatine phosphokinase strikingly increased post-race (163.4 &#177; 56.8 vs. 2978.4 &#177; 1921.9 U/L; p &lt; 0.001) and was inversely correlated with distance covered: those who covered the longest distances showed the lowest CPK levels (Pearson r = 0.69, p = 0.02). After the race, 2 runners showed a slight increase in Troponin levels. One of them also had simultaneous decrease in left ventricular ejection fraction (coronary artery disease was subsequently ruled out). Basal echocardiography assessment had shown LV hypertrophy in one and increased left atrial volume in five runners. After the race, there was a decrease in E/A ratio (p &lt; 0.01).</p>
      <p><bold> CONCLUSION:</bold> Prolonged physical exercise is associated with metabolic and cardiovascular alterations. Cardiac abnormalities found in our study suggest that cardiac fatigue may occur in this specific race modality. The long-term effect of these alterations, while maintaining the routine practice of prolonged strenuous physical activity, is still unknown.</p>
      <p><bold>Keywords:</bold> Exercise; physical exertion; running; muscle fatigue.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The regular practice of physical exercise is associated with beneficial effects on the control of risk factors and reducing cardiovascular mortality<sup>1</sup>. There seems to be a positive association between dose and response to physical training, but the intensity from which there would be harmful effects on the cardiovascular system is still unknown.</p>
      <p>Running is an increasingly popular type of sports practice worldwide. Each year, the number of events of this type of sport multiplies and the number of individuals who participate in these events increases significantly. This growing popularity, together with the constant pursuit of humans to overcome their limitations, gives rise to extremely challenging evidence. Consequently, there is increasing concern about the acute effects and possible risks that such activities can bring to the athletes. The very origin of the marathon is associated with the report of a case of sudden death.</p>
      <p>The evidence that strenuous exercise can cause alterations in the metabolism and cardiovascular system are derived from several sporting events<sup>2-6</sup>. A meta-analysis of 26 studies demonstrated that troponin elevation occurs in approximately half of the participants of endurance tests, and this increase appears to be more common in shorter duration tests<sup>7</sup>. Moreover, the acute effects of continuous and prolonged physical activity remain poorly explored.</p>
      <p>The ultramarathon is defined as a race with distance greater than the official marathon (42,195 meters) and may vary according to certain range or time limit. Studies evaluating the cardiovascular effects of different types of this modality are scarce. The aim of this study was to evaluate the metabolic and hematological effects and cardiovascular alterations induced by a 24-hour ultramarathon, of which goal is to travel the longest distance within this time period.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This study was approved by the research ethics committee (REC) of Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225; (PUC - PR) and the free and informed consent form (ICF) was obtained from each participant prior to study inclusion.</p>
      <p>The study was carried out at the "Ultramaratona 24 h - Corrotododia 2008" sports event, held in Curitiba, state of Parana, Brazil, on 05/17/2008. The broadcasting and initial information about the study were made available on the website of the event, along with the registration form. Runners who had interest in participating in the study were contacted by e-mail and sent an invitation letter and other information. The event had a total of 51 runners (nine women and 42 men).</p>
      <p>
        <bold>Inclusion and exclusion criteria</bold>
      </p>
      <p>We included only male runners with experience in at least one long-distance competition and no history of cardiopulmonary diseases. Exclusion criteria were: not completing the 24-hour race or not performing blood collection or echocardiogram at any of the two moments (pre-and post-race).</p>
      <p>
        <bold>Study protocol</bold>
      </p>
      <p>The race was held on an outdoor athletics track with 400 m, and every two hours the race athletes alternated the direction of the race. The alternation is performed for psychological reasons, primarily to avoid monotony and also physical reasons, preventing musculoskeletal unilateral overload. A research station was set up at the site of the event, with all the material needed for data collection. All athletes completed an identification questionnaire with information on health status and history of sports practice.</p>
      <p>During the competition they had free access to fluids (water, soft drinks and sports drink beverages) and carbohydrate-rich food (fruits, noodles, mashed potatoes and sandwiches) available in support tents along the track.</p>
      <p>Likewise, they were allowed to rest during the race for as long as necessary. However, the athletes had to complete the 24-hour race.</p>
      <p>
        <bold>Clinical and laboratory assessment</bold>
      </p>
      <p>The runners were submitted to clinical evaluation to obtain anthropometric data before and after the race. After weighing, at both moments, bioelectrical impedance was carried out in a tetrapolar device Maltron BF 906. For that purpose, the athlete was placed in the supine position on a stretcher, with the right foot and hand slightly away from the trunk. The distal electrodes of the feet were placed at the base of the middle toe, and the proximal ones between the medial and lateral malleoli. In the hands, the distal electrodes were placed at the base of the middle finger, with the proximal electrodes coinciding with the styloid process.</p>
      <p>Venous blood samples were obtained the day before the race and immediately after. At each phase, 20 ml of blood were collected. The samples were immediately stored on ice and protected from light. In the laboratory, the blood plasma was separated by centrifugation at 3000 rpm for 15 minutes and stored in a freezer at - 20 &#186;C until the analysis was performed. Each sample underwent complete blood count and analysis of urea, creatinine, creatine phosphokinase (CPK), creatine kinase-MB (CK-MB), potassium and cardiac troponin T (cTnT).</p>
      <p>
        <bold>Echocardiography</bold>
      </p>
      <p>Complete echocardiographic study (including two-dimensional, M-mode and Doppler) was performed the night before the race and immediately after it, at the same place where the event was held. The device used was an Agilant Sonos 5500, Philips, equipped with a 2.5 MHz transducer. All images were obtained by the same echocardiographist (SHB) and analyzed during runtime.</p>
      <p>The following linear measurements were obtained by the M mode: interventricular septum thickness in diastole, left ventricular systolic and diastolic diameter (LVSD and LVDD), and left ventricular (LV) posterior wall thickness in diastole.</p>
      <p>The LV mass was calculated according to the equation of the American Society of Echocardiography and indexed by body surface, diagnosing LV hypertrophy when the indexed mass was &gt; 115 g/m<sup>2</sup>. LV systolic function was assessed by ejection fraction (EF), which was calculated by the Teichholz method. The mitral inflow velocities in pulsed Doppler were recorded at the apical four-chamber view with the sample volume positioned at the extremities of the mitral valve leaflets during calm and controlled breathing. Early rapid filling (E) wave velocity, atrial contraction (A) wave velocity and E / A ratio were estimated in accordance with the recommendations of the American Society of Echocardiography.</p>
      <p>The early (E') and late (A') diastolic mitral annular velocities at tissue Doppler and their ratio (E'/A') were recorded in the apical four-chamber view with a sample volume of 1 mm at the junction between the LV lateral wall with the annulus. The left atrium (LA) size was calculated by estimating the left atrial volume (LAV), which was determined by biplane Simpson's method at the two-dimensional echocardiography and indexed by body surface. All measurements represent the mean of three cardiac cycles.</p>
      <p>The intraobserver variability for echocardiographic variables evaluated in this study has been previously published by our group<sup>8,9</sup>.</p>
      <p>
        <bold>Statistical Analysis</bold>
      </p>
      <p>Results are expressed as mean, median, minimum and maximum values and standard deviations. To assess the impact of the race on the data obtained in the two predetermined moments (pre- and post-race), the Student's <italic>t</italic> test was used for paired samples. The variables' normality was analyzed by the Shapiro-Wilks test. P values &lt; 0.05 were considered statistically significant.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>A total of 20 athletes were included in the study. Twelve completed the 24-hour race and participated in all stages of the study. Of the eight eliminated, three did not complete the race due to physical problems and five did not participate in some stage of the evaluation. The mean age of the 12 participants was 43.3 &#177; 9.9 years. The mean distance covered during the race was 140.32 km, ranging from 111.60 km and 169.60 km. The temperature during the 24 hours ranged from 9-21 &#186;C.</p>
      <p>
        <bold>Clinical, anthropometric and laboratory data</bold>
      </p>
      <p>In relation to the pre-race moment, runners had weight reduction, with a mean loss of 3.2% of the initial weight. Data from bioimpedance analysis showed no change in body composition of water. Despite this finding, there was a significant reduction in systolic (120.8 &#177; 6.7 in pre- <italic>vs</italic>. 103.3 &#177; 8.9 in post-race, p &lt;0.001) and diastolic blood pressure (83.3 &#177; 10.7 <italic>vs</italic>. 73.3 &#177; 8.9, p = 0.003). The clinical and anthropometric data are summarized in <xref ref-type="table" rid="en_11512tab01-body2">Table 1</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_11512tab01-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt01-en.jpg"/></table-wrap>
      </p>
      <p>Regarding laboratory findings, there was a marked increase in CPK levels, a sensitive marker of muscle injury. This increase was accompanied by increased urea, serum creatinine and decreased kalemia. At the hematological analysis, we observed significant leukocytosis, predominantly by neutrophilia. Laboratory data are shown in <xref ref-type="table" rid="en_11512tab02-body2">Table 2</xref>. As shown in <xref ref-type="fig" rid="en_11512fig01-body2">Figure 1</xref>, CPK levels after the race had an inverse correlation with the distance covered during the marathon.</p>
      <p content-type="asset">
        <table-wrap id="en_11512tab02-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt02-en.jpg"/></table-wrap>
      </p>
      <p content-type="asset">
        <fig id="en_11512fig01-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gf01-en.jpg"/></fig>
      </p>
      <p>
        <bold>Markers of myocardial necrosis</bold>
      </p>
      <p>There was a marked increase in CK-MB levels. However, such alteration occurred in parallel to the elevation in CPK levels (<xref ref-type="table" rid="en_11512tab02-body2">Table 2</xref>).</p>
      <p>Regarding troponin T, the values found in the pre-race measurement were below the threshold of detection (0.010 ng/mL). After the race, two athletes showed increased values (0.015 and 0.018 ng/mL), but below the reference value for the detection of myocardial injury.</p>
      <p>
        <bold>Echocardiographic findings</bold>
      </p>
      <p>In the pre-race assessment, all athletes had normal ventricular systolic and diastolic function. Left ventricular hypertrophy was found in one and left atrial volume increase in five runners.</p>
      <p>The mean LVDD decreased significantly (p &lt;0.01), while the LVSD and EF remained unchanged after the race.</p>
      <p>Regarding LV diastolic function, we observed a decrease in E/A ratio after the race (p = 0.001). This change was mainly due to an increase in the values of A (p &lt;0.001), with no changes in the value of E. In parallel, we observed decrease in E' velocity and increase in A' velocity, which, although not significant, led to a threshold variation of E'/A' (p = 0.05). Finally, there was no change in LAV. The echocardiographic findings are described in <xref ref-type="table" rid="en_11512tab03-body2">Table 3</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_11512tab03-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0021-00118-gt03-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Cardiac fatigue</bold>
      </p>
      <p>One athlete, the oldest to complete the marathon (63 years), showed a significant decrease in LVEF: 70% pre- and 51% post-test. The dysfunction was global, with no change in segmental contraction. Clinically, there was also marked tachydyspnea upon arrival. This athlete was subsequently assessed with myocardial perfusion imaging and coronary CT angiography, which ruled coronary disease or other structural heart disease. Please note that this was one of two athletes to show troponin elevation, although below the reference value for the diagnosis of myocardial injury.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>Although the beneficial effects of exercise on overall health have been demonstrated long ago, the acute effects of prolonged aerobic training remain unclear, especially on the heart. Prolonged athletic competitions such as ultramarathons and other competitions involving multiple sports (such as Ironman and Ultraman) become unique opportunities for this type of assessment. As there are few athletes qualified to perform such tests, studies in this area generally comprise a small number of individuals. Therefore, the results of this study are added to others, previously published ones, in order to assess whether physical exercise is always beneficial or if its excess can endanger health.</p>
      <p>Many of the alterations observed in our study confirm the results of previous investigations in prolonged endurance events. It is known that CPK levels increase after great physiological stress<sup>10-17</sup>, indicating intense catabolic state of skeletal muscle. The intensity and duration of physical exercise are commonly associated with CPK increase and there seems to be a predominant effect of duration<sup>16</sup>. Although rare, severe rhabdomyolysis can occur, albeit more commonly in less-trained individuals subjected to strenuous exercise at high temperatures<sup>18</sup>. It is noteworthy in our study the close inverse association observed between CPK levels and the covered distance. Athletes who covered the greatest distances had lower levels of CPK, showing that the volume of the effort is not necessarily the major determinant of the increase. One can assume that the best physical fitness, which led athletes to cover longer distances, also prevented major muscle catabolism. Previous studies have shown that exercise training actually reduces the release of CPK in the same individual<sup>19</sup>.</p>
      <p>The increase of urea and creatinine is another common finding in strenuous physical training tests, but its meaning is less clear. While it may reflect large degradation of muscle creatine, we found no correlation between creatinine variation and CPK increase (data not shown). Other mechanisms may be associated with these elevations, such as decrease in renal blood flow and glomerular filtration rate. Mild, but persistent kidney injury has been demonstrated in some high-performance athletes<sup>20</sup>. The hypovolemia itself may be one of the causes of increased creatinine<sup>15</sup>. Increased urea can be explained by the increased catabolic state.</p>
      <p>Among the metabolic alterations we observed a slight kalemia decrease in the runners. This finding is opposed to what is described in the literature regarding the alterations in this electrolyte levels due to exercise practice<sup>11</sup>. The possibility of adequate nutrition and hydration during the race possibly contributed to the lack of more significant electrolyte alterations.</p>
      <p>The absence of alterations in the bioimpedance should be interpreted with caution, as its performance immediately after intense physical exercise can reduce its accuracy for the measurement of total body water. Hemodynamic alterations, such as increased cardiac output and skeletal muscle perfusion, and the process of heat dissipation, with cutaneous vasodilation, increased skin temperature and sweating, reduce the body impedance, affecting the results. This could have limited the bioimpedance analysis to detect dehydration inferred by body weight measurement. Fluid intake was free and at the discretion of the athlete in this study in order to evaluate the effects of prolonged exercise in the conditions under which this type of test is usually performed. We observed that the mean weight reduction was 3.2%, which is within the range of significant dehydration according to the National Athletic Trainer's Association<sup>21</sup>.</p>
      <p>However, the estimate of the degree of dehydration based on changes in weight has been questioned. Recently, Knechtle et al<sup>22</sup> found a mean reduction of 2.5% in the weight of athletes after a 100-km ultramarathon, which can not be totally explained by the reduction in total body water, suggesting that the loss resulted from solid mass loss (muscle mass and fat).</p>
      <p>There was no change in hematocrit or hemoglobin levels similar to what was found in previous studies with ultramarathon runners<sup>23</sup>. The increased activity of vasopressin and plasma aldosterone, promoting the maintenance or increasing plasma volume is a possible explanation for this finding. The leukocyte alterations were in accordance with what is expected in stress situations. There was significant leukocytosis with marked formation of neutrophils. Lymphocyte alterations showed more divergent results, although some studies corroborate our findings on lymphocytosis<sup>11</sup>.</p>
      <p>Regarding the assessment of myocardial injury in athletes, it is essential to correctly interpret laboratory test results. As the skeletal injury also alters markers that are commonly used in myocardial assessment, sensitive and specific markers such as cardiac troponins I and T, should be used. The assessment of CPK and CKMB fails to differentiate myocardial injury from the one that occurs in skeletal muscle. Several studies, such as ours, showed no elevation in TnT, even with significant increases in CKMB<sup>24-28</sup>. Others showed an increase of this marker in a heterogeneous group of athletes<sup>29-33</sup>, although it is not known whether this increase really reflects myocardial damage and what the determinants of alteration are in just some athletes.</p>
      <p>An experimental study by Chen et al<sup>34</sup> in rats showed that the extent of myocardial lesions induced by strenuous physical exertion is dependent on the previous physical fitness. If this is an explanation for the discrepant findings in humans, it is still a hypothesis to be tested. However, a small study of marathoners actually showed greater troponin release in less trained runners<sup>35</sup>. In a meta-analysis, Shave et al<sup>36</sup> showed that the release of cTnT induced by exercise is evident in almost half of endurance athletes, with the relatively heavier athletes, competing in long distance events, being more likely to show such release.</p>
      <p>While no athlete in this study showed troponin increases above the reference value for the diagnosis of myocardial damage, two runners started to show detectable levels after the race. In a previous study with participants of an Ironman competition, even minor alterations of troponin were associated with echocardiographic abnormalities<sup>37</sup>. These changes constitute the picture of cardiac fatigue, an entity described several years ago, but of which etiology remains unclear. It is believed that the stress generated by exercise on the left and right ventricular walls is the origin of these alterations<sup>38</sup>. The increase in plasma brain natriuretic peptide (BNP) in endurance athletes reinforces this idea<sup>39</sup>.</p>
      <p>In our sample, the only athlete who had a significant decrease in LVEF at the end of the race was exactly the one that showed an increase, albeit slight, of troponin levels. As the possibility of ischemic injury was ruled out by functional (myocardial scintigraphy) and anatomical examination (CT angiography of coronary arteries), the established diagnosis was cardiac fatigue. However, the finding of reduced LVEF in this patient was isolated. The echocardiography showed no decrease in LV systolic function, demonstrating that, in the other runners, exercise intensity was not sufficient to induce significant deterioration in cardiac contractility.</p>
      <p>Regarding the diastolic function, the echocardiographic finding of a significant decrease in E/A ratio, commonly interpreted as the onset of diastolic dysfunction has been previously described<sup>40</sup>. Here it is necessary to perform a critical appraisal of the term "diastolic dysfunction" after prolonged exercise. Although this conclusion comes from data derived from conventional Doppler mitral flow (known to be dependent on preload), our study showed only a marginal variation in the E'/A' ratio, this obtained by tissue Doppler and less susceptible to loading status<sup>9</sup>. Thus, on the one hand there may have been an insufficient number of cases to demonstrate significant differences in the E' and A' velocities that would corroborate the hypothesis of actual diastolic dysfunction, but, on the other hand, the decrease in E/A ratio after exercise may simply correlate with preload reduction.</p>
      <p>In parallel, we must emphasize that this alteration was secondary to an increase in A wave (atrial contraction phase), with no alteration in the values of E (rapid filling phase). Similarly, as it is reasonable to assume that the decrease in LV diameter was due to the decrease in preload, one may speculate that the increase in A wave may be secondary to concomitant decrease in afterload, with increases in atrial contractility and ventricular compliance. Therefore, the decrease in E/A ratio n did not represent actual diastolic dysfunction (except in the aforementioned case of cardiac fatigue), but the complex effect of hemodynamic changes on the total blood volume and cardiovascular physiology. Future studies should clarify whether strenuous physical exertion promotes actual myocardial relaxation injury.</p>
      <p>Our study has some limitations. The number of subjects included in the study was not based on sample-size calculation, but on the total number of individuals who agreed to participate in this research. As it is a strenuous test, the number of participants was small. Still, approximately 50% of the male runners agreed to participate, a higher percentage than in most publications with similar populations. Another limitation was the lack of evaluation of the runners' aerobic capacity. A preliminary assessment of maximal oxygen consumption (VO2 max) would allow better understanding if certain findings did not reflect, actually, lower cardiorespiratory fitness.</p>
      <p>Finally, a single assessment after the marathon does not allow any inference on the temporal evolution of metabolic and cardiovascular alterations found. As most runners were from other cities, further assessment was not feasible.</p>
      <p>In conclusion, the ultramarathon race was associated with several metabolic, hematologic and cardiovascular alterations. Regarding skeletal muscle, we observed a lower level of injury in runners who covered greater distances. Slight increase in cTnT was associated with LV systolic dysfunction in one runner, which was compatible with cardiac fatigue. In the others, the finding of a decrease in the E/A ratio on mitral Doppler predominated. The long-term effect of this type of prolonged physical exercise is still unknown.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the master thesis submitted by Daniela G. Passaglia, from Pontif&#237;cia Universidade Cat&#243;lica do Paran&#225;.</p>
      <p>
        <bold>Refer&#234;ncias</bold>
      </p>
    </body>
  </sub-article>
</article>
